Encodia
Encodia is a biotechnology company that specializes in protein sequencing using its proprietary ProteoCode™ technology, aimed at advancing human health innovations.
Company Overview
Encodia is a biotechnology company located at 5785 Oberlin Dr, San Diego, CA 92121. The company focuses on advancing human health through innovative protein sequencing technology. Its main product, ProteoCode™, leverages reverse-translation technology to provide scalable and in-depth protein analysis. Encodia aims to accelerate innovations in personalized medicine and multiomic approaches.
ProteoCode™ Technology
ProteoCode™ is Encodia's proprietary reverse-translation technology designed for protein sequencing at scale. This next-generation sequencing (NGS)-based technology uses amino acid barcoded libraries to achieve scale and throughput comparable to traditional genomics technology. ProteoCode™ provides comprehensive insights into cellular processes, facilitating advancements in personalized medicine. The technology is scalable to population-level studies and integrates seamlessly with multiomic approaches.
Location
Encodia is headquartered at 5785 Oberlin Dr, San Diego, CA 92121. The location situates the company within a vibrant biotech community, fostering collaborations and innovations in the field of human health and protein sequencing technologies.
Next-Generation Sequencing-Based Protein Analysis
Encodia offers next-generation sequencing (NGS)-based protein analysis through its ProteoCode™ technology. The technology uses amino acid barcoded libraries to achieve high scale and throughput, comparable to genomics technologies. This approach enables in-depth cellular process analysis and contributes to the development of personalized medicine solutions.